van den Brink MRM - Search Results

1

Reconstitution of the gut microbiota of antibiotic-treated patients by autologous fecal microbiota transplant.

Taur Y, Coyte K, Schluter J, Robilotti E, Figueroa C, Gjonbalaj M, Littmann ER, Ling L, Miller L, Gyaltshen Y, Fontana E, Morjaria S, Gyurkocza B, Perales MA, Castro-Malaspina H, Tamari R, Ponce D, Koehne G, Barker J, Jakubowski A, Papadopoulos E, Dahi P, Sauter C, Shaffer B, Young JW, Peled J, Meagher RC, Jenq RR, van den Brink MRM, Giralt SA, Pamer EG, Xavier JB. Taur Y, et al. Among authors: van den brink mrm. Sci Transl Med. 2018 Sep 26;10(460):eaap9489. doi: 10.1126/scitranslmed.aap9489. Sci Transl Med. 2018. PMID: 30257956 Free PMC article. Clinical Trial.

2

Administration of interleukin-7 after allogeneic bone marrow transplantation improves immune reconstitution without aggravating graft-versus-host disease.

Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA, Halm JA, Rich BE, van den Brink MR. Alpdogan O, et al. Blood. 2001 Oct 1;98(7):2256-65. doi: 10.1182/blood.v98.7.2256. Blood. 2001. PMID: 11568014 Free article.

3

Septic shock and multiple organ failure after hematopoietic stem cell transplantation: treatment with recombinant human activated protein C.

Pastores SM, Papadopoulos E, van den Brink M, Alicea M, Halpern NA. Pastores SM, et al. Bone Marrow Transplant. 2002 Jul;30(2):131-4. doi: 10.1038/sj.bmt.1703618. Bone Marrow Transplant. 2002. PMID: 12132053

4

Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.

Lewin SR, Heller G, Zhang L, Rodrigues E, Skulsky E, van den Brink MR, Small TN, Kernan NA, O'Reilly RJ, Ho DD, Young JW. Lewin SR, et al. Blood. 2002 Sep 15;100(6):2235-42. Blood. 2002. PMID: 12200390 Free article.

5

Remodeling specific immunity by use of MHC tetramers: demonstration in a graft-versus-host disease model.

Kappel BJ, Pinilla-Ibarz J, Kochman AA, Eng JM, Hubbard VM, Leiner I, Pamer EG, Heller G, van den Brink MR, Scheinberg DA. Kappel BJ, et al. Blood. 2006 Mar 1;107(5):2045-51. doi: 10.1182/blood-2005-07-2828. Epub 2005 Nov 3. Blood. 2006. PMID: 16269613 Free PMC article.

6

TLR1 and TLR6 polymorphisms are associated with susceptibility to invasive aspergillosis after allogeneic stem cell transplantation.

Kesh S, Mensah NY, Peterlongo P, Jaffe D, Hsu K, VAN DEN Brink M, O'reilly R, Pamer E, Satagopan J, Papanicolaou GA. Kesh S, et al. Ann N Y Acad Sci. 2005 Dec;1062:95-103. doi: 10.1196/annals.1358.012. Ann N Y Acad Sci. 2005. PMID: 16461792

7

Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Zakrzewski JL, Kochman AA, Lu SX, Terwey TH, Kim TD, Hubbard VM, Muriglan SJ, Suh D, Smith OM, Grubin J, Patel N, Chow A, Cabrera-Perez J, Radhakrishnan R, Diab A, Perales MA, Rizzuto G, Menet E, Pamer EG, Heller G, Zúñiga-Pflücker JC, Alpdogan O, van den Brink MR. Zakrzewski JL, et al. Nat Med. 2006 Sep;12(9):1039-47. doi: 10.1038/nm1463. Epub 2006 Aug 27. Nat Med. 2006. PMID: 16936725

8

DNA immunization against tissue-restricted antigens enhances tumor immunity after allogeneic hemopoietic stem cell transplantation.

Perales MA, Diab A, Cohen AD, Huggins DW, Guevara-Patiño JA, Hubbard VM, Engelhorn ME, Kochman AA, Eng JM, Mortazavi F, Alpdogan O, Terwey TH, Heller G, Wolchok JD, Houghton AN, van den Brink MR. Perales MA, et al. J Immunol. 2006 Sep 15;177(6):4159-67. doi: 10.4049/jimmunol.177.6.4159. J Immunol. 2006. PMID: 16951381

9

T cell depleted stem-cell transplantation for adults with hematologic malignancies: sustained engraftment of HLA-matched related donor grafts without the use of antithymocyte globulin.

Jakubowski AA, Small TN, Young JW, Kernan NA, Castro-Malaspina H, Hsu KC, Perales MA, Collins N, Cisek C, Chiu M, van den Brink MR, O'Reilly RJ, Papadopoulos EB. Jakubowski AA, et al. Blood. 2007 Dec 15;110(13):4552-9. doi: 10.1182/blood-2007-06-093880. Epub 2007 Aug 23. Blood. 2007. PMID: 17717135 Free PMC article. Clinical Trial.

10

Fludarabine-based conditioning secures engraftment of second hematopoietic stem cell allografts (HSCT) in the treatment of initial graft failure.

Chewning JH, Castro-Malaspina H, Jakubowski A, Kernan NA, Papadopoulos EB, Small TN, Heller G, Hsu KC, Perales MA, van den Brink MR, Young JW, Prockop SE, Collins NH, O'Reilly RJ, Boulad F. Chewning JH, et al. Biol Blood Marrow Transplant. 2007 Nov;13(11):1313-23. doi: 10.1016/j.bbmt.2007.07.006. Epub 2007 Sep 7. Biol Blood Marrow Transplant. 2007. PMID: 17950918 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

295 results

Search Page